CanniMed

History and Milestones

• Prairie Plant Systems (PPS) established in 1988, initially providing fruit trees.
• PPS ventured into medical cannabis growth in 2000.
• CanniMed received Health Canada approval for clinical trials in 2015.
• Health Canada changed regulations in 2013, impacting CanniMed’s operations.
• CanniMed was the sole licensed cannabis grower until 2013.

Regulations, Acquisitions, and Corporate Changes

• CanniMed merged with Aurora Cannabis in 2018 for $1.1 billion.
• Aurora acquired 96% of CanniMed stock by March 2018.
• The CEO of CanniMed resigned in April 2018 following the acquisition.
• Aurora announced the closure of the Saskatoon facility in June 2020.

Expansion, Partnerships, and Market Performance

• CanniMed announced a $10 million facility expansion in 2017.
• Deal with PharmaChoice for product distribution in 2017.
• Proposed merger with Newstrike Resources in 2017.
• CanniMed’s stock price surged around the 2018 legalization.
• CanniMed reconsidered Aurora’s offer in 2018.

Products, Approvals, and Research Initiatives

• CanniMed received approval to sell edible cannabis oil in 2016.
• Clinical trial approval for cannabis in osteoarthritis patients in 2015.
• CanniMed’s subsidiary, SubTerra, made acquisitions for research.
• CanniMed’s U.S. subsidiary was established in 2000.
• CanniMed’s IPO raised $69 million in 2016.

References and Media Coverage

• Various news sources covered CanniMed’s journey and milestones.
• Health Canada approved CanniMed’s cannabis oil sale.
• Prairie Plant Systems’ clean innovation was highlighted in the industry.
• Aurora finalized the acquisition of CanniMed in 2018.
• CEO resignation and interim CEO appointment were reported in the media.

CanniMed Data Sources